SBRA Quote, Financials, Valuation and Earnings

LTC Properties, Inc. has a net margin of 13.72% compared to Sabra Health Care REIT, Inc.'s net margin of -26.43%. Sabra Health Care REIT, Inc.'s return on equity of 5.63% beat LTC Properties, Inc.'s return on equity of 11.5%.

Sabra Health Care REIT, Inc. has a consensus price target of $21.69, signalling upside risk potential of 6.23%. On the other hand LTC Properties, Inc. has an analysts' consensus of $39.29 which suggests that it could fall by -0.49%. Given that Sabra Health Care REIT, Inc. has higher upside potential than LTC Properties, Inc., analysts believe Sabra Health Care REIT, Inc. is more attractive than LTC Properties, Inc..

Sabra Health Care REIT, Inc. has a beta of 0.645, which suggesting that the stock is 35.538% less volatile than S&P 500. In comparison LTC Properties, Inc. has a beta of 0.595, suggesting its less volatile than the S&P 500 by 40.515%.

Sabra Health Care REIT, Inc. has a quarterly dividend of $0.30 per share corresponding to a yield of 5.88%. LTC Properties, Inc. offers a yield of 5.78% to investors and pays a quarterly dividend of $0.19 per share. Sabra Health Care REIT, Inc. pays 188.56% of its earnings as a dividend. LTC Properties, Inc. pays out 90.52% of its earnings as a dividend. LTC Properties, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but Sabra Health Care REIT, Inc.'s is not.

Sabra Health Care REIT, Inc. quarterly revenues are $197.9M, which are larger than LTC Properties, Inc. quarterly revenues of $84.4M. Sabra Health Care REIT, Inc.'s net income of $27.1M is lower than LTC Properties, Inc.'s net income of $103.4M. Notably, Sabra Health Care REIT, Inc.'s price-to-earnings ratio is 31.91x while LTC Properties, Inc.'s PE ratio is 16.06x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Sabra Health Care REIT, Inc. is 6.45x versus 6.92x for LTC Properties, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Omega Healthcare Investors, Inc. has a net margin of 13.72% compared to Sabra Health Care REIT, Inc.'s net margin of 53.44%. Sabra Health Care REIT, Inc.'s return on equity of 5.63% beat Omega Healthcare Investors, Inc.'s return on equity of 11.93%.

Sabra Health Care REIT, Inc. has a consensus price target of $21.69, signalling upside risk potential of 6.23%. On the other hand Omega Healthcare Investors, Inc. has an analysts' consensus of $49.06 which suggests that it could grow by 3.38%. Given that Sabra Health Care REIT, Inc. has higher upside potential than Omega Healthcare Investors, Inc., analysts believe Sabra Health Care REIT, Inc. is more attractive than Omega Healthcare Investors, Inc..

Sabra Health Care REIT, Inc. has a beta of 0.645, which suggesting that the stock is 35.538% less volatile than S&P 500. In comparison Omega Healthcare Investors, Inc. has a beta of 0.544, suggesting its less volatile than the S&P 500 by 45.629%.

Sabra Health Care REIT, Inc. has a quarterly dividend of $0.30 per share corresponding to a yield of 5.88%. Omega Healthcare Investors, Inc. offers a yield of 5.65% to investors and pays a quarterly dividend of $0.67 per share. Sabra Health Care REIT, Inc. pays 188.56% of its earnings as a dividend. Omega Healthcare Investors, Inc. pays out 138.19% of its earnings as a dividend. Neither of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Sabra Health Care REIT, Inc. quarterly revenues are $197.9M, which are smaller than Omega Healthcare Investors, Inc. quarterly revenues of $321.8M. Sabra Health Care REIT, Inc.'s net income of $27.1M is lower than Omega Healthcare Investors, Inc.'s net income of $172M. Notably, Sabra Health Care REIT, Inc.'s price-to-earnings ratio is 31.91x while Omega Healthcare Investors, Inc.'s PE ratio is 24.57x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Sabra Health Care REIT, Inc. is 6.45x versus 12.08x for Omega Healthcare Investors, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

UMH Properties, Inc. has a net margin of 13.72% compared to Sabra Health Care REIT, Inc.'s net margin of 6.83%. Sabra Health Care REIT, Inc.'s return on equity of 5.63% beat UMH Properties, Inc.'s return on equity of 2.86%.

Sabra Health Care REIT, Inc. has a consensus price target of $21.69, signalling upside risk potential of 6.23%. On the other hand UMH Properties, Inc. has an analysts' consensus of $19.36 which suggests that it could grow by 28.45%. Given that UMH Properties, Inc. has higher upside potential than Sabra Health Care REIT, Inc., analysts believe UMH Properties, Inc. is more attractive than Sabra Health Care REIT, Inc..

Sabra Health Care REIT, Inc. has a beta of 0.645, which suggesting that the stock is 35.538% less volatile than S&P 500. In comparison UMH Properties, Inc. has a beta of 1.068, suggesting its more volatile than the S&P 500 by 6.78%.

Sabra Health Care REIT, Inc. has a quarterly dividend of $0.30 per share corresponding to a yield of 5.88%. UMH Properties, Inc. offers a yield of 5.97% to investors and pays a quarterly dividend of $0.23 per share. Sabra Health Care REIT, Inc. pays 188.56% of its earnings as a dividend. UMH Properties, Inc. pays out 1264.21% of its earnings as a dividend. Neither of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Sabra Health Care REIT, Inc. quarterly revenues are $197.9M, which are larger than UMH Properties, Inc. quarterly revenues of $67M. Sabra Health Care REIT, Inc.'s net income of $27.1M is higher than UMH Properties, Inc.'s net income of $4.6M. Notably, Sabra Health Care REIT, Inc.'s price-to-earnings ratio is 31.91x while UMH Properties, Inc.'s PE ratio is 215.29x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Sabra Health Care REIT, Inc. is 6.45x versus 4.87x for UMH Properties, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Ventas, Inc. has a net margin of 13.72% compared to Sabra Health Care REIT, Inc.'s net margin of 4.66%. Sabra Health Care REIT, Inc.'s return on equity of 5.63% beat Ventas, Inc.'s return on equity of 2.16%.

Sabra Health Care REIT, Inc. has a consensus price target of $21.69, signalling upside risk potential of 6.23%. On the other hand Ventas, Inc. has an analysts' consensus of $90.90 which suggests that it could grow by 4.68%. Given that Sabra Health Care REIT, Inc. has higher upside potential than Ventas, Inc., analysts believe Sabra Health Care REIT, Inc. is more attractive than Ventas, Inc..

Sabra Health Care REIT, Inc. has a beta of 0.645, which suggesting that the stock is 35.538% less volatile than S&P 500. In comparison Ventas, Inc. has a beta of 0.733, suggesting its less volatile than the S&P 500 by 26.7%.

Sabra Health Care REIT, Inc. has a quarterly dividend of $0.30 per share corresponding to a yield of 5.88%. Ventas, Inc. offers a yield of 2.22% to investors and pays a quarterly dividend of $0.48 per share. Sabra Health Care REIT, Inc. pays 188.56% of its earnings as a dividend. Ventas, Inc. pays out 353.33% of its earnings as a dividend. Neither of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Sabra Health Care REIT, Inc. quarterly revenues are $197.9M, which are smaller than Ventas, Inc. quarterly revenues of $1.6B. Sabra Health Care REIT, Inc.'s net income of $27.1M is lower than Ventas, Inc.'s net income of $73M. Notably, Sabra Health Care REIT, Inc.'s price-to-earnings ratio is 31.91x while Ventas, Inc.'s PE ratio is 159.54x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Sabra Health Care REIT, Inc. is 6.45x versus 6.86x for Ventas, Inc.. Usually stocks with elevated PS ratios are considered overvalued.